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doi:10.1016/j.jmu.2011.08.002Solid pseudopapillary tumor (SPT) is a very rare neoplasm of the exocrine pancreas. SPT usually
develops asymptomatically and therefore radiological techniques are very important in the
diagnosis. Frequently, ultrasound examination is the first technique that is used, and although
it is not very specific, it may be completed with contrast-enhanced ultrasound, which
increases diagnostic accuracy. Unlike other pancreatic neoplasms, SPT has a homogeneous
filling in the arterial phase and is well defined by peripheral rim enhancement in the early
dynamic phase. We report the clinical and imaging features of a case of SPT, as well as the
surgical treatment and postoperative complications.
ª 2011, Elsevier Taiwan LLC and the Chinese Taipei Society of Ultrasound in Medicine.
Open access under CC BY-NC-ND license.Introduction
Solid pseudopapillary tumor (SPT) is a very rare neoplasm of
the exocrine pancreas that mainly affects young women. Ifcopet, Third Medical Clinic,
ganu University of Medicine
0163 Cluj-Napoca, Romania.
mail.com (B. Procopet).
C and the Chinese Taipei Societydiagnosed in time, it can benefit from curative surgery with
excellent survival rates. The main diagnostic tools are
radiological techniques. Ultrasound (US) examination is
usually the first technique that is used and may suggest the
diagnosis. Moreover, US is important in the postsurgical
setting to evaluate the possible complications. Abdominal
computed tomography (CT), magnetic resonance imaging
(MRI) and endoscopic ultrasound-guided fine-needle aspi-
ration (EUS-FNA) are more accurate diagnostic tools.of Ultrasound in Medicine. Open access under CC BY-NC-ND license.
100 R. Badea et al.In this paper, we describe the clinical and imaging
features of a case of SPT, as well as the surgical treatment
and postoperative complications.
Case report
A 20-year-old woman, with no remarkable medical history,
was admitted because of a 1-month history of epigastric
pain, nausea and vomiting. Her physical examination was
unremarkable, except for epigastric tenderness. The only
laboratory test abnormality was a slight increase in serum
amylase at 148 U/L (normal value <100 U/L) and discrete
augmentation of carbohydrate antigen 19-9 antigen at
32.69 IU/L (normal value <19 IU/L).
The US examination (Logiq 7; General Electric, Milwau-
kee, WI, USA) revealed a 92 mm  58 mm  43 mm, mixed
solid and cystic mass in the pancreatic body and tail
(Fig. 1A). The tumor was well-defined and had a closeFig. 1 (A) Ultrasound examination (transverse section)
showing a well-defined mixed mass in the pancreatic body and
tail. (B) Contrast-enhanced ultrasound (transverse section)
showing homogeneous filling of the tumor in the arterial phase
and the presence of peripheral rim enhancement (arrows).contact with splenic and superior mesenteric veins. Color
Doppler examination confirmed the permeability of these
veins. Intravenous contrast-enhanced ultrasound (CEUS) in
pulse-inversion mode at a mechanical index of 0.09, after
1.6 mL bolus injection of the contrast agent SonoVue
(Bracco, Milano, Italy) showed a homogeneous vascular
pattern of the solid part of the tumor, with a relatively
slow washout (28e30 seconds) compared to the normal
pancreatic parenchyma (Fig. 1B). The tumor was well-
defined by an enhanced rim around the mass in the early
phase. There were no signs of local extension or hepatic
metastases in the portal phase. No other pathological
findings were described at US examination.
EUS-FNA was non-contributive because of the lack of
sufficient biopsy material. However, endoscopic ultrasound
was able to eliminate local tumoral extension.
During laparoscopic surgery, a pancreatic tumor was
identified extending from the bodyetail pancreatic junc-
tion to the splenic hilum. Given the close contact of the
tumor with the splenic vessels, their excision was neces-
sary. The spleen vascularization was kept through the
gastro-splenic ligament, permitting sparing of the spleen.
Histological examination revealed an SPT of the pancreas,
with specific immunohistochemical profile (vimentin, neuron-
specific enolase and CD10 positivity).
In the postsurgical survey, no signs of sepsis or hemody-
namic instability were noted. After splenic vessel branches
excision, a control US examination was made 7 days after
surgery. This revealed a well-delimited liquid collection in
the pancreatic area, which was interpreted as a postsurgical
hematoma (Fig. 2A). The spleen volume was significantly
increased, with a well-delimited hypo-echogenic area
situated at the inferior pole. CEUS excluded an active
retroperitoneal hemorrhage and the lack of contrast
enhancement in the hypo-echogenic splenic area suggested
a splenic infarction (Fig. 2B). The patient was asymptom-
atic and therefore conservative management was chosen.
Given the favorable evolution, the patient was discharged.
Evaluation at 6 weeks and 3 months showed resolution of
the postsurgical hematoma and scarring of the spleen
infarction lesion.Discussion
SPT of the pancreas is a very rare neoplasm, with a low
malignancy potential [1]. It represents 1e2% of the
pancreatic neoplasms and is more frequent in young women
[2]. This neoplasm rarely affects men, in which case it has
the tendency to develop 10 years later than in women [3]. A
recent review of the medical literature has described 718
well-documented cases of SPT between 1933 and 2003 [4].
This neoplasm was first described by Frantz in 1959 [5],
and the term SPT was recently established by the World
Health Organization working group for studying pancreatic
tumors [6], after a period of many years during which this
tumor was named in many different ways.
SPT usually develops asymptomatically, but when
symptomatic, the most frequent symptom is abdominal
pain, followed by evidence of an upper abdominal mass at
the physical examination. The first symptom may rarely be
jaundice, if the tumor is situated in the pancreatic head. At
Fig. 2 (A) Postsurgical ultrasound examination (transverse
section) revealed an inhomogeneous pancreatic area and the
presence of a hematoma (arrows). (B) Postoperative contrast-
enhanced ultrasound examination of the spleen (longitudinal
section) showed normal spleen parenchyma (asterisk), splenic
artery with contrast agent (pointed arrow), and infarction area
(arrow).
Solid Pseudopapillary Pancreatic Tumor 101diagnosis, SPT is usually a large tumor, with a reported
mean diameter of 6.1e8.4 cm [4,7]. More frequently, this
neoplasm is located in the body and tail of the pancreas
(72%) [8]. The multicentric [9] or extrapancreatic forms
[10,11] have rarely been described. Given the long doubling
time, the prognosis of SPT is good even in the presence of
metastasis [4], and therefore radical surgical treatment
may offer a high survival rate.
CT and MRI are important imaging techniques that
suggest the diagnosis of SPT. CT scan usually reveals an
encapsulated tumor with possible areas of cystic degener-
ation, necrosis or hemorrhage [12]. Also, calcifications may
be present. EUS-FNA has recently gained ground for eval-
uation of pancreatic tumors. The accuracy of EUS-FNA for
diagnosis of SPT is superior to that of CT and MRI [13]. Also,
it allows tumor biopsy, which permits immunohistochemical
examination to differentiate SPT from other pancreatictumors. Contrast-enhanced harmonics endoscopic ultraso-
nography permits a more accurate description of tumoral
vascular pattern [14].
US examination is frequently the first radiological tech-
nique in the management of these patients. The US aspects
are not specific, but the clinical context and the evidence
of a well-defined tumor may suggest SPT.
With CEUS, SPT has a homogeneous filling in the arterial
phase and incomplete washout in the venous phase, due to
the persistence of the contrast agent in the tumoral
microcirculation. This specific behavior allows differential
diagnosis from the high malignancy tumor, which remains
more hypoechogenic during the arterial phase [15].
Frequently, the tumor is well-defined by a peripheral rim
enhancement in the early dynamic phase. This corresponds
to the tumor pseudocapsule, which results from the
compression of the pancreatic tissue [16].
US examination may be useful in postsurgical follow-up
to evaluate the local postoperative complications. In our
case, US examination and CEUS revealed the presence of
a postsurgical hematoma and spleen infarction. CEUS could
be an important investigative technique to rule out active
hemorrhage, as demonstrated by a lack of contrast agent
inside the hematoma [17]. In addition to hemodynamic
stability, these findings were decisive for a conservative
approach in our case. Given the typical echographic aspect,
US examination is accurate for the diagnosis of spleen
infarction, whereas CEUS is more accurate for description
of the infarction area [18].
Due to low malignancy potential, SPT is elective for
radical surgical treatment, which provides excellent long-
term survival. Distal pancreatectomy, with or without
splenectomy, may be performed for tumors of the body or
tail of the pancreas, and pancreaticoduodenectomy for
tumors of the pancreatic head.
In conclusion, SPT is an uncommon pancreatic neoplasm,
which may benefit from an excellent prognosis if diagnosed
and treated surgically. US examination is often the first
radiological technique and provides the first evaluation of
pancreatic tumors. The combination of multiple US proce-
dures (two-dimensional, Doppler and CEUS) improves the
diagnostic accuracy and allows accessible follow-up in the
postsurgical setting, to detect possible complications.Financial disclosure
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